Literature DB >> 17635983

Heterogeneity in male to female risk for Parkinson's disease.

K S M Taylor, J A Cook, C E Counsell.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17635983      PMCID： PMC2117744          DOI： 10.1136/jnnp.2006.104695

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  10 in total

1.  Incidence of Parkinson disease in Wakayama, Japan.

Authors:  Seiji Morioka; Kiyomi Sakata; Sohei Yoshida; Ekini Nakai; Mitsuru Shiba; Noriko Yoshimura; Tsutomu Hashimoto
Journal:  J Epidemiol       Date:  2002-11       Impact factor: 3.211

2.  Pilot study of the incidence and prognosis of degenerative Parkinsonian disorders in Aberdeen, United Kingdom: methods and preliminary results.

Authors:  Kate S M Taylor; Carl E Counsell; Clare E Harris; Joanna C Gordon; W Cairns S Smith
Journal:  Mov Disord       Date:  2006-07       Impact factor: 10.338

3.  Parkinson's disease and parkinsonism in a longitudinal study: two-fold higher incidence in men. ILSA Working Group. Italian Longitudinal Study on Aging.

Authors:  M Baldereschi; A Di Carlo; W A Rocca; P Vanni; S Maggi; E Perissinotto; F Grigoletto; L Amaducci; D Inzitari
Journal:  Neurology       Date:  2000-11-14       Impact factor: 9.910

4.  Incidence of Parkinson disease and parkinsonism in three elderly populations of central Spain.

Authors:  J Benito-León; F Bermejo-Pareja; J M Morales-González; J Porta-Etessam; R Trincado; S Vega; E D Louis
Journal:  Neurology       Date:  2004-03-09       Impact factor: 9.910

5.  Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity.

Authors:  Stephen K Van Den Eeden; Caroline M Tanner; Allan L Bernstein; Robin D Fross; Amethyst Leimpeter; Daniel A Bloch; Lorene M Nelson
Journal:  Am J Epidemiol       Date:  2003-06-01       Impact factor: 4.897

6.  Incidence of parkinsonism and Parkinson disease in a general population: the Rotterdam Study.

Authors:  L M L de Lau; P C L M Giesbergen; M C de Rijk; A Hofman; P J Koudstaal; M M B Breteler
Journal:  Neurology       Date:  2004-10-12       Impact factor: 9.910

Review 7.  Systematic review of incidence studies of Parkinson's disease.

Authors:  Dominique Twelves; Kate S M Perkins; Carl Counsell
Journal:  Mov Disord       Date:  2003-01       Impact factor: 10.338

8.  Incidence of Parkinson's disease in estonia.

Authors:  Pille Taba; Toomas Asser
Journal:  Neuroepidemiology       Date:  2003 Jan-Feb       Impact factor: 3.282

9.  Are men at greater risk for Parkinson's disease than women?

Authors:  G F Wooten; L J Currie; V E Bovbjerg; J K Lee; J Patrie
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-04       Impact factor: 10.154

10.  The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study.

Authors:  Thomas Foltynie; Carol E G Brayne; Trevor W Robbins; Roger A Barker
Journal:  Brain       Date:  2003-12-22       Impact factor: 13.501
  10 in total
  62 in total

1.  Gender differences in the risk of familial parkinsonism: beyond LRRK2?

Authors:  R Saunders-Pullman; K Stanley; M San Luciano; M J Barrett; V Shanker; D Raymond; L J Ozelius; S B Bressman
Journal:  Neurosci Lett       Date:  2011-04-12       Impact factor: 3.046

Review 2.  Parkinson's disease in women: a call for improved clinical studies and for comparative effectiveness research.

Authors:  J M Pavon; H E Whitson; M S Okun
Journal:  Maturitas       Date:  2010-02-01       Impact factor: 4.342

3.  Sex and Parkinson's disease: a world of difference?

Authors:  David J Burn
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-08       Impact factor: 10.154

Review 4.  Epidemiology of Parkinson's disease.

Authors:  Guido Alves; Elin Bjelland Forsaa; Kenn Freddy Pedersen; Michaela Dreetz Gjerstad; Jan Petter Larsen
Journal:  J Neurol       Date:  2008-09       Impact factor: 4.849

Review 5.  Parkinson's disease: fetal cell or stem cell-derived treatments.

Authors:  Arnar Astradsson; Tipu Z Aziz
Journal:  BMJ Clin Evid       Date:  2015-04-21

Review 6.  Do Microglial Sex Differences Contribute to Sex Differences in Neurodegenerative Diseases?

Authors:  Lay Kodama; Li Gan
Journal:  Trends Mol Med       Date:  2019-06-03       Impact factor: 11.951

7.  Using Canadian Primary Care Sentinel Surveillance Network data to examine depression in patients with a diagnosis of Parkinson disease: a retrospective cohort study.

Authors:  Kimberly Rose P Singian; Morgan Price; Vicky Bungay; Sabrina T Wong
Journal:  CMAJ Open       Date:  2016-08-08

8.  Low Levels of Prohibitin in Substantia Nigra Makes Dopaminergic Neurons Vulnerable in Parkinson's Disease.

Authors:  Debashis Dutta; Nilufar Ali; Emili Banerjee; Raghavendra Singh; Amit Naskar; Ramesh Kumar Paidi; Kochupurackal P Mohanakumar
Journal:  Mol Neurobiol       Date:  2017-01-06       Impact factor: 5.590

9.  Evidence for gender-specific transcriptional profiles of nigral dopamine neurons in Parkinson disease.

Authors:  Filip Simunovic; Ming Yi; Yulei Wang; Robert Stephens; Kai C Sonntag
Journal:  PLoS One       Date:  2010-01-25       Impact factor: 3.240

Review 10.  Alterations in the E3 ligases Parkin and CHIP result in unique metabolic signaling defects and mitochondrial quality control issues.

Authors:  Britney N Lizama; Amy M Palubinsky; BethAnn McLaughlin
Journal:  Neurochem Int       Date:  2017-08-26       Impact factor: 3.921
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.